Close Menu

During his keynote address at the Genetics Society of America: Model Organisms to Human Biology meeting in Boston this week, National Institute of General Medical Sciences director Jeremy Berg spoke about advances in pharmacogenomics related to warfarin dosing, the recent NIH-wide changes to grant applications, and NIGMS genetics and genomics resources for those who study model organisms, "from A to Z — from Arabidopsis to zebrafish." Berg also spoke about how investigators who use model organisms in their work might be most likely to receive NIGMS funding for their work.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.